Stahnke et al. found human Granzyme B to confer specific killing to primary CD64-positive cells from an acute myeloid leukemia (AML) patient ex vivo and to AML-related cell line U937 in vitro after delivery by H22(scFv). This evidence concerns the gene GZMB and acute myeloid leukemia.